Medicare Enrolled
Dr. Maureen Eisenberg, D.O.
Family Medicine · Hanover, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Eisenberg from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Eisenberg?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Eisenberg
Dr. Maureen Eisenberg is a family medicine specialist in Hanover, PA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Eisenberg performed 9,192 Medicare services across 2,862 unique beneficiaries.
Between the years covered by Open Payments, Dr. Eisenberg received a total of $10,434 from 51 pharmaceutical and/or device companies across 794 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Eisenberg is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 0% volume in PA
$10,434 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,192
Medicare services
Top 0% in PA for family medicine
2,862
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~438 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 5,580 | $18 | $37 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
444 | $84 | $172 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
386 | $8 | $12 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
281 | $57 | $110 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
241 | $29 | $41 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
235 | $72 | $91 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
217 | $7 | $57 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
186 | $125 | $219 |
| Annual depression screening | 185 | $18 | $25 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
172 | $2 | $9 |
| COVID-19 vaccine administration Administration of a single dose of the coronavirus vaccine. |
168 | $39 | $52 |
| COVID-19 vaccine (Pfizer bivalent) Administration of a 30 mcg dose of the SARS-CoV-2 vaccine via intramuscular injection. |
168 | $128 | $170 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
135 | $10 | $35 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
95 | $4 | $12 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
93 | $282 | $360 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
91 | $28 | $29 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
87 | $16 | $51 |
| Annual alcohol misuse screening, 5 to 15 minutes | 58 | $18 | $26 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
56 | $16 | $25 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
43 | $125 | $245 |
| Adm sarscv2 bvl 50mcg/.5ml a | 40 | $39 | $52 |
| COVID-19 immunoassay detection test A laboratory test that uses an immunoassay method to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) through direct visual observation. |
36 | $41 | $54 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
25 | $36 | $130 |
| SARS-CoV-2 vaccine, 30 mcg/0.3 mL Administration of the SARS-CoV-2 (COVID-19) vaccine containing 30 micrograms of antigen in a 0.3 milliliter dose. |
24 | $39 | $52 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
24 | $23 | $176 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
20 | $3 | $19 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
20 | $158 | $240 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
17 | $212 | $340 |
| Vaccine administration The process of giving a vaccine to a patient. This code covers the administration service only and does not include the cost of the vaccine itself. |
15 | $14 | $34 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
13 | $37 | $130 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $38 | $66 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
13 | $161 | $244 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
11 | $17 | $32 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,434
Total received (2018-2024)
Avg $1,491/year across 7 years
Top 5% in PA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
794
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,434 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,755
2023
$1,833
2022
$1,728
2021
$1,539
2020
$1,163
2019
$1,116
2018
$1,300
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$422
GlaxoSmithKline, LLC.
$217
Lilly USA, LLC
$210
AstraZeneca Pharmaceuticals LP
$164
ABBVIE INC.
$150
PFIZER INC.
$108
Merck Sharp & Dohme LLC
$106
Janssen Pharmaceuticals, Inc
$58
Dexcom, Inc.
$46
Phathom Pharmaceuticals, Inc.
$44
Amgen Inc.
$40
E.R. Squibb & Sons, L.L.C.
$40
Exact Sciences Corporation
$36
IDORSIA PHARMACEUTICALS US INC
$30
SANOFI PASTEUR INC.
$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$18
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Currax Pharmaceuticals LLC
$14
Top 3 companies account for 48.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,699
GlaxoSmithKline, LLC.
$1,362
Boehringer Ingelheim Pharmaceuticals, Inc.
$832
ABBVIE INC.
$721
Lilly USA, LLC
$628
AstraZeneca Pharmaceuticals LP
$559
PFIZER INC.
$550
Merck Sharp & Dohme LLC
$373
AbbVie Inc.
$298
Janssen Pharmaceuticals, Inc
$295
E.R. Squibb & Sons, L.L.C.
$276
Amgen Inc.
$267
Merck Sharp & Dohme Corporation
$262
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$245
Takeda Pharmaceuticals U.S.A., Inc.
$203
Astellas Pharma US Inc
$178
SANOFI-AVENTIS U.S. LLC
$145
SANOFI PASTEUR INC.
$122
Daiichi Sankyo Inc.
$116
Amarin Pharma Inc.
$116
IBSA Pharma Inc.
$108
Novartis Pharmaceuticals Corporation
$98
Bayer HealthCare Pharmaceuticals Inc.
$91
Otsuka America Pharmaceutical, Inc.
$75
Phathom Pharmaceuticals, Inc.
$61
Biohaven Pharmaceutical Holding Company Ltd.
$59
Exact Sciences Corporation
$56
Biohaven Pharmaceuticals, Inc.
$55
Kowa Pharmaceuticals America, Inc.
$53
Dexcom, Inc.
$46
Allergan Inc.
$41
Axsome Therapeutics, Inc.
$39
Sanofi Pasteur Inc.
$36
IDORSIA PHARMACEUTICALS US INC
$30
Allergan, Inc.
$30
NESTLE HEALTHCARE NUTRITION INC.
$30
Grifols USA, LLC
$29
Nestle HealthCare Nutrition Inc.
$28
Teva Pharmaceuticals USA, Inc.
$26
AbbVie, Inc.
$23
Abbott Laboratories
$23
Relypsa, Inc.
$18
Xeris Pharmaceuticals, Inc.
$18
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$18
Radius Health, Inc.
$16
Esperion Therapeutics, Inc.
$15
Bayer Healthcare Pharmaceuticals Inc.
$15
Impulse Dynamics (USA) Inc.
$14
Currax Pharmaceuticals LLC
$14
Eisai Inc.
$13
IRONWOOD PHARMACEUTICALS, INC
$12
Top 3 companies account for 37.3% of all-time payments
Associated products mentioned in payments ›
ADACEL · ADVAIR · AIMOVIG · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · AREXVY · Aimovig · Auvelity · BASAGLAR · BELSOMRA · BEXSERO · BEYFORTUS · BREO · BREZTRI · BYDUREON · BYSTOLIC · CAPLYTA · CHANTIX · COMIRNATY · CREON · Cologuard Collection Kit · Creon · Dayvigo · Dexcom G6 Transmitter · Dexilant · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE HIGH-DOSE · FreeStyle Libre 2 · GARDASIL · GARDASIL 9 · GVOKE PFS · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LICART · LINZESS · LYRICA · Licart · Linzess · Livalo · MOUNJARO · MYRBETRIQ · Myrbetriq · NEXLETOL · NO PRODUCT DISCUSSED · NURTEC ODT · ONZETRA XSAIL · OPTIMIZER · Otezla · Ozempic · PAXLOVID · PENTACEL · PNEUMOVAX 23 · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PROQUAD · Prolastin-C · Prolastin-C Liquid · Prolia · QULIPTA · QUVIVIQ · REXULTI · ROTATEQ · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SIVEXTRO · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · Saxenda · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tirosint · Tresiba · Trintellix · Tymlos · UBRELVY · VESICARE · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Veltassa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · ZENPEP · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for family medicine in PA.
Geographic Context
Family medicine physicians within 10 mi
374
Per 100K population
81.4
County median income
$82,238
Nearest hospital
UPMC HANOVER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Eisenberg is a mixed practice specialist, with above-average Medicare volume (top 0% in PA), with low-engagement industry engagement in the top 5% of PA peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Eisenberg experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Eisenberg performed 5,580 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Eisenberg receive payments from pharmaceutical companies?
Yes. Dr. Eisenberg received a total of $10,434 from 51 companies across 794 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Eisenberg's costs compare to other family medicine physicians in Hanover?
Dr. Eisenberg's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Eisenberg) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Hanover
Browse family medicine physicians in Hanover ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in PA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in PA
Which PA family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology